Skip to main content
Clinical Trials/NCT06577727
NCT06577727CompletedNot Applicable

A Study to Collect Data to Build Artificial Intelligence Derived Algorithms for Estimating Iron Status of Children (FERROUS 2)

Danone Asia Pacific Holdings Pte, Ltd.2 sites in 2 countries250 target enrollmentStarted: January 15, 2025Last updated:
Conditions
Interventions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Enrollment
250
Locations
2
Primary Endpoint
Accuracy of the Iron AI in a clinic setting

Study Overview

Brief Summary

An exploratory study to collect data to build artificial intelligence derived algorithms for estimating iron status in children

Detailed Description

This is an exploratory, observational, pilot study that aims to build and measure the accuracy of an algorithm that estimates a child's iron status using images and/or videos, against gold standard venous blood sampling. Images and/or videos will be collected by healthcare professionals, together with blood test results. This data will be used to evaluate the accuracy of the algorithm and to explore potential improvements. Data on the acceptance and experience of the using the algorithm will be collected for improvements.

Study Design

Study Type
Observational
Observational Model
Cohort
Time Perspective
Prospective

Eligibility Criteria

Ages
6 Months to 72 Months (Child)
Sex
All
Accepts Healthy Volunteers
Yes

Inclusion Criteria

  • Children above 6 months of age and below 6 years of age
  • Written consent from parent(s) or legally acceptable representative(s), who themselves are aged ≥ 21 years old, to consent and comply with the terms and conditions of the study
  • Parent(s) should have access to the internet and a smartphone or tablet to complete study questionnaires
  • Parent(s) should be able to comprehend the content of the study and complete the study questionnaires
  • Parents(s) must be comfortable with their child having blood draws
  • Subject has a Hb level corresponding to a Hb group with open slots for participation

Exclusion Criteria

  • Children with any medical condition that in the opinion of the investigator would not be suitable for enrolment.
  • Children with nail bed obstructions, nail polish, nails discolouration (e.g., leukonychia, melanonychia, bruising, etc.), or scarring of the lips, pigmentations on lips for thyroid dysfunction (e.g., Puettz-jeghers syndrome).
  • Children who are unable to cooperate with study procedures.
  • Employees and/or children/family members or relatives of employees of Danone Global Research & Innovation Center or the participating sites.

Arms & Interventions

Children aged 6-72 months of age

Approximately 250 children aged above 6 months old and below 6 years of age across potential study sites.

Subjects will be grouped by haemoglobin (Hb) level ranging from <6 g/dL to ≥ 14.0 g/dL. There will be a minimum of 10 subjects and a maximum of 25 subjects for each group.

Intervention: Gold standard blood test (Other)

Children aged 6-72 months of age

Approximately 250 children aged above 6 months old and below 6 years of age across potential study sites.

Subjects will be grouped by haemoglobin (Hb) level ranging from <6 g/dL to ≥ 14.0 g/dL. There will be a minimum of 10 subjects and a maximum of 25 subjects for each group.

Intervention: Imaging and videography of anatomical sites (Other)

Outcomes

Primary Outcomes

Accuracy of the Iron AI in a clinic setting

Time Frame: 1 day

Accuracy of the Iron Ai in a clinic setting, derived from: 1. The Iron AI prediction from images/videos collected 2. The gold standard blood test results

Secondary Outcomes

  • Parental acceptability of the Iron AI(1 day)
  • Investigator's (or delegates) acceptability of Iron AI(1 day)

Investigators

Sponsor Class
Industry
Responsible Party
Sponsor

Study Sites (2)

Loading locations...

Similar Trials

A Study to Collect Data to Build... | Clinical Trial